InsiderTrades

Form 4 for INKT MiNK Therapeutics, Inc.

Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001193125-26-102581 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2026-03-11 2026-03-09+ INKT Ryan Barbara Dir S - Sale $14.70 -1,500 21.4K -7% -$22.1K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-10 S D 500 $15.30 20,406 D — — (F1) The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors.
2 Common Common Stock 2026-03-10 S D 500 $15.57 20,906 D — — (F1) The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors.
3 Common Common Stock 2026-03-09 S D 200 $10.17 21,706 D — — (F1) The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors.
4 Common Common Stock 2026-03-10 S D 300 $15.28 21,406 D — — (F1) The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors.